Menu

A Reprogramming Histone

The scientist who pioneered cloning has found that a histone may act as a cellular reset button.  

Oct 29, 2012
Beth Marie Mole

Wikimedia, Toni BarrosIn the 1996 experiment that created the famous sheep Dolly, researchers swapped the nucleus of an unfertilized egg with that of a differentiated adult cell, which rebooted the adult nucleus to create the first cloned mammal. Now, John B. Gurdon of the Gurdon Institute in Cambridge and colleagues—who developed the technique and shared the Nobel Prize in Physiology or Medicine this year—have found that a histone variant, H3.3, plays a central role in transitioning an adult cell’s nucleus to a blank-slate capable of developing into any of the body’s cells.

"Manipulating the H3.3 pathway may provide a way to completely wipe a cell's ‘memory’ and produce a truly pluripotent cell,” geneticist Steven Henikoff, from the Fred Hutchinson Cancer Research Center, said in a press release. The results, published today (October 29) in Epigenetics & Chromatin, could have implications for regenerative medicine and other therapies, he added, which are beginning to use reprogrammed cells but still face difficulties, including low efficiency. “[It] suggests that chromatin is a sticking point preventing artificially induced reprogramming [from] being used routinely in the clinic."

For the experiment, Gurdon and colleagues implanted a nucleus from an adult mouse cell into an enucleated frog egg—similar to his first groundbreaking nuclear transfer experiment in 1962—and added fluorescently labeled histones, around which strands of DNA wrap, making certain genes available or unavailable for transcription.

"Using real-time microscopy it became apparent that from 10 hours onwards, H3.3 . . . became incorporated into the transplanted nucleus,” explained Gurdon in the press release. The team noted that H3.3’s placement in the DNA coincided with regions important for the regulation of key pluripotency genes, such as Oct4. The researchers also found that the nucleus wouldn’t reprogram without H3.3 present.

The finding suggests that this histone variant is necessary for global genome changes that control the cell fate, the authors wrote in the study.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.